Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 145-147

Informa Healthcare

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

By Petit Thierry  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 387-391

Springer Publishing Company

Access to resources Recommend Favorite

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

By Rocca Andrea   Viale Giuseppe   Gelber Richard   Bottiglieri Luca   Gelber Shari   Pruneri Giancarlo   Ghisini Raffaella   Balduzzi Alessandra   Pietri Elisabetta   D’Alessandro Claudia   Goldhirsch Aron   Colleoni Marco  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 965-971

Springer Publishing Company

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite